S Verver
How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control
Verver, S; Walker, M; Kim, Y E; Fobi, G; Tekle, A H; Zouré, H G M; Wanji, S; Boakye, D A; Kuesel, A C; De Vlas, S J; Boussinesq, M; Basáñez, M-G; Stolk, W A
Authors
M Walker
Y E Kim
G Fobi
A H Tekle
H G M Zouré
S Wanji
D A Boakye
A C Kuesel
S J De Vlas
M Boussinesq
M-G Basáñez
W A Stolk
Citation
Verver, S., Walker, M., Kim, Y. E., Fobi, G., Tekle, A. H., Zouré, H. G. M., …Stolk, W. A. (2018). How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control. Clinical Infectious Diseases, 66(4), S267-S274. https://doi.org/10.1093/cid/cix1137
Journal Article Type | Article |
---|---|
Acceptance Date | May 30, 2018 |
Publication Date | Jun 1, 2018 |
Deposit Date | Mar 8, 2018 |
Publicly Available Date | Jul 9, 2018 |
Journal | CLINICAL INFECTIOUS DISEASES |
Print ISSN | 1058-4838 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 66 |
Issue | 4 |
Pages | S267-S274 |
DOI | https://doi.org/10.1093/cid/cix1137 |
Public URL | https://rvc-repository.worktribe.com/output/1387022 |
Files
11236.pdf
(1.7 Mb)
PDF
You might also like
Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
(2023)
Journal Article
Is the incidence of congenital toxoplasmosis declining?
(2022)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search